Concord Medical Services Announces the Appointment of Mr. Adam Sun as Acting Chief Financial Officer
BEIJING, Aug. 31, 2011 /PRNewswire-Asia-FirstCall/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company", NYSE: CCM), the operator of the largest network of radiotherapy and diagnostic imaging centers in China, today announced that the Company has appointed Mr. Adam Jigang Sun as Acting Chief Financial Officer, effective on September 1, 2011. Mr. Adam Sun will replace the current Chief Financial Officer, Mr. Steve Sun, who will continue to serve as Co-chairman of the Board of Directors.
Mr. Steve Sun will focus on leading Concord Medical's network expansion and strategic acquisitions in addition to other duties as a member of the Board.
Mr. Adam Sun will oversee the Company's finance and reporting functions, as well as assist Mr. Steve Sun in managing the Company's network expansion and strategic acquisitions. Mr. Adam Sun and Mr. Steve Sun are not related.
Mr. Adam Sun has more than 10 years of experience in finance and management. From January 2011 to August 2011, Mr. Adam Sun served as the CFO of a subsidiary of Asia Pacific Medical Group, a privately-held health management company based in Beijing, where he participated in the acquisition of a private hospital in Beijing. From June 2010 to December 2010, Mr. Sun was the Vice President of Corporate Development of China Ritar Power Corp., a publicly traded battery manufacturer, where he was responsible for corporate planning, acquisitions, and investor relations. From December 2008 to June 2010, Mr. Sun served as the CFO of Shijiazhuang Gongda Chemical Engineering Equipment Co., Ltd. ("Gongda"), a Chinese supplier of process-engineering equipment and solutions. His CFO duties at Gongda included helping complete a private equity financing by strategic investors. From 2004 to 2008, Mr. Sun co-founded and led a financial advisory firm, IA Exchange, Inc., that specialized in pro